Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published March 15, 2011 | Accepted Version
Journal Article Open

Quantitative pharmacologic MRI: Mapping the cerebral blood volume response to cocaine in dopamine transporter knockout mice

Abstract

The use of pharmacologic MRI (phMRI) in mouse models of brain disorders allows noninvasive in vivo assessment of drug-modulated local cerebral blood volume changes (ΔCBV) as one correlate of neuronal and neurovascular activities. In this report, we employed CBV-weighted phMRI to compare cocaine-modulated neuronal activity in dopamine transporter (DAT) knockout (KO) and wild-typemice. Cocaine acts to block the dopamine, norepinephrine, and serotonin transporters (DAT, NET, and SERT) that clear their respective neurotransmitters from the synapses, helping to terminate cognate neurotransmission. Cocaine consistently reduced CBV, with a similar pattern of regional ΔCBV in brain structures involved inmediating reward in both DAT genotypes. The largest effects (−20% to −30% ΔCBV) were seen in the nucleus accumbens and several cortical regions. Decreasing response amplitudes to cocaine were noted in more posterior components of the cortico-mesolimbic circuit. DAT KO mice had significantly attenuated ΔCBV amplitudes, shortened times to peak response, and reduced response duration in most regions. This study demonstrates that DAT knockout does not abolish the phMRI responses to cocaine, suggesting that adaptations to loss of DAT and/or retained cocaine activity in other monoamine neurotransmitter systems underlie these responses in DAT KO mice.

Additional Information

© 2010 Elsevier Inc. Received 17 May 2010; revised 15 December 2010; accepted 17 December 2010. Available online 23 December 2010. The authors thank Hargun Sohi and Thomas Ng for their technical assistance, Davit Janvelyan for helping with the AIR software, Guerbet Research (Aulnay-Sous-Bois, France) for providing the P904 contrast agent. This project was funded in part by the Beckman Institute, NIDA R01DA18184, and NCRR U24 RR021760 Mouse BIRN and by funding from the National Institute on Drug Abuse, Intramural Research Program (GRU, FSH).

Attached Files

Accepted Version - nihms260897.pdf

Files

nihms260897.pdf
Files (805.8 kB)
Name Size Download all
md5:dad76db73d6439a42e6973b29e9a4108
805.8 kB Preview Download

Additional details

Created:
August 19, 2023
Modified:
October 23, 2023